Optinose to Present at the BMO 2020 Prescriptions for Success Healthcare Conference
YARDLEY, Pa., June 22, 2020 (GLOBE NEWSWIRE) — Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose […]
Digital Ally, Inc. Regains Compliance With Nasdaq Minimum Market Value of Listed Securities Requirement
Market Value of Listed Securities Exceeds $35 million at Closing for Ten Consecutive Trading DaysLenexa, KS, June 22, 2020 (GLOBE […]
Allogene Therapeutics Announces Publication Highlighting Potential for ALLO-819 In Acute Myeloid Leukemia
FLT3-Directed AlloCAR T™ Therapy Demonstrated Potent Anti-Leukemic Activity in Pre-Clinical Models Without Evidence of Off-Target Activity SOUTH SAN FRANCISCO, Calif., June […]
WeedMD Launches Cannabis 2.0 Product Line of Medical Vaporizers
Strain-specific ‘Aurum’ vapes produced in-house at Company’s CX Industries’ facility expands Company’s medical product portfolioAdult-use brand “Color Cannabis” vaporizers slated […]
Manitou Gold Provides Update on Exploration Activities at its 100% Owned Goudreau Project in Northern Ontario
SUDBURY, Ontario, June 22, 2020 (GLOBE NEWSWIRE) — Manitou Gold Inc. (TSX-V: MTU) (the “Company” or “Manitou”) is pleased to […]
Myovant Sciences Announces Priority Review and FDA Acceptance of New Drug Application for Once-Daily, Oral Relugolix for Advanced Prostate Cancer
Priority Review status expected to accelerate review, with a target FDA action date of December 20, 2020BASEL, Switzerland, June 22, […]
Saratoga Investment Corp. to Report Fiscal First Quarter 2021 Financial Results and Hold Conference Call
NEW YORK, June 22, 2020 (GLOBE NEWSWIRE) — Saratoga Investment Corp. (NYSE:SAR), a business development company, will report its financial […]
Micro-Measurements Launches New E-Commerce Capability for Strain Gage Customers
MALVERN, Pa., June 22, 2020 (GLOBE NEWSWIRE) — The Micro-Measurements® brand of Vishay Precision Group, Inc. (NYSE: VPG), a leading […]
Corbus Pharmaceuticals Reports Last Subject Visit in Phase 2b Study of Lenabasum for Treatment of Cystic Fibrosis
Topline data on schedule for Q3 2020Reduction in pulmonary exacerbations (PEx) as primary endpointStudy enrolled 426 participants regardless of CFTR […]
Ceapro Announces Results of 2020 Shareholders’ Meeting
EDMONTON, Alberta, June 22, 2020 (GLOBE NEWSWIRE) — Ceapro Inc. (TSX-V: CZO; OTCQX: CRPOF) (“Ceapro” or the “Company”), a growth-stage […]
